Omar Ibrahim

Dr. Omar Ibrahim

Washington University in St. Louis, St Louis, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in Nature
Verified
Journal Article
Open access
PDF file
NTNadezhda V. Terekhanova
Nadezhda V. Terekhanova
AKAlla Karpova
Alla Karpova
WLWen-Wei Liang
Wen-Wei Liang
ASAlexander Strzalkowski
Alexander Strzalkowski
SCSiqi Chen
Siqi Chen
LDLi Ding
Li Ding
Chromatin accessibility is essential in regulating gene expression and cellular identity, and alterations in accessibility have been implicated in driving cancer initiation, progression and metastasis1–4. Although the genetic contributions to oncogenic transitions have been investigated, epigenetic drivers remain less understood. Here we constructed a pan-cancer epigenetic and transcriptomic atlas using single-nucleus chromatin accessibility data (using single-nucleus assay for transposase-accessible chromatin) from 225 samples and matched single-cell or single-nucleus RNA-sequencing expression data from 206 samples. With over 1 million cells from each platform analysed through the enrichment of accessible chromatin regions, transcription factor motifs and regulons, we identified epigenetic drivers associated with cancer transitions. Some epigenetic drivers appeared in multiple cancers (for example, regulatory regions of ABCC1 and VEGFA; GATA6 and FOX-family motifs), whereas others were cancer specific (for example, regulatory regions of FGF19, ASAP2 and EN1, and the PBX3 motif). Among epigenetically altered pathways, TP53, hypoxia and TNF signalling were linked to cancer initiation, whereas oestrogen response, epithelial–mesenchymal transition and apical junction were tied to metastatic transition. Furthermore, we revealed a marked correlation between enhancer accessibility and gene expression and uncovered cooperation between epigenetic and genetic drivers. This atlas provides a foundation for further investigation of epigenetic dynamics in cancer transitions.

1 June 2020 in Carbohydrate Polymers
Verified
Journal Article
Closed access
Mohamed Ramadan ElAassarMohamed Ramadan ElAassar
Mohamed Ramadan ElAassar
OIOmar Ibrahim
Omar Ibrahim
MFMoustafa Fouda
Moustafa Fouda
NENagham G. El-Beheri
Nagham G. El-Beheri
MAMona Agwa
Mona Agwa

1 March 2021 in Carbohydrate Polymers
Verified
Journal Article
Closed access
Mohamed Ramadan ElAassarMohamed Ramadan ElAassar
Mohamed Ramadan ElAassar
OIOmar Ibrahim
Omar Ibrahim
MFMoustafa Fouda
Moustafa Fouda
HFHala Fakhry
Hala Fakhry
JAJamaan Ajarem
Jamaan Ajarem
EHElsayed E. Hafez
Elsayed E. Hafez

17 February 2022 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
NENehal M. El-Deeb
Nehal M. El-Deeb
OIOmar Ibrahim
Omar Ibrahim
MMMahmoud A. Mohamed
Mahmoud A. Mohamed
MFMohamed M.S. Farag
Mohamed M.S. Farag
AFAyman A. Farrag
Ayman A. Farrag
Mohamed Ramadan ElAassarMohamed Ramadan ElAassar
Mohamed Ramadan ElAassar

21 July 2020 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
NENehal M. El-Deeb
Nehal M. El-Deeb
MAMai A. Abo-Eleneen
Mai A. Abo-Eleneen
LALamiaa A. Al-Madboly
Lamiaa A. Al-Madboly
MSMona M. Sharaf
Mona M. Sharaf
SOSarah S. Othman
Sarah S. Othman
Mohammad MubarakMohammad Mubarak
Mohammad Mubarak
Bacterial infections are the key cause of death in patients suffering from burns and diabetic wounds while the use of traditional antibiotics has been growing steadily. Thus, in the present study, we are trying to introduce a paradigm shift strategy to improve chronic wound healing of bacterial infection. To that end, we have biologically synthesized silver nanoparticles (AgNPs) using Arthrospira sp polysaccharides, and evaluated their antibacterial efficacy with their safety pattern. Scanning electron micrographs showed spherical AgNPs coated with algal polysaccharides with an approximate size of 9.7 nm. Treatment of Pseudomonas aeruginosa with the AgNPs (0.5–1 μg/mL) resulted in a significant disruption in P. aeruginosa outer membrane, reduction in biofilm formation, and a significant decrease of production of alginate and pyocyanin along with a concentration-dependent reduction in β-lactamase activity. In addition, at the in vivo level, AgNPs displayed substantial activity to control P. aeruginosa infections in rat skin wounds with significant reduction in in COX-2 enzyme in both rat skin homogenate and serum samples. Furthermore, AgNPs facilitated wound curative in the P. aeruginosa infected model by reducing the hemorrhagic areas number and the infiltrated inflammatory cells. Taken all together, these biogenic nanoparticles showed unique properties in controlling bacterial wound infections and improving the healing process of damaged tissues via its direct and indirect effects.

13 February 2023 in Cancer Research
Verified
Journal Article
Open access
PDF file
LYLijun Yao
Lijun Yao
JWJulia T. Wang
Julia T. Wang
RJReyka G. Jayasinghe
Reyka G. Jayasinghe
JOJulie O'NEal
Julie O'NEal
CTChia-Feng Tsai
Chia-Feng Tsai
JDJohn F DiPersio
John F DiPersio
Multiple myeloma (MM) is a highly refractory hematologic cancer. Targeted immunotherapy has shown promise in MM but remains hindered by the challenge of identifying specific yet broadly representative tumor markers. We analyzed 53 bone marrow (BM) aspirates from 41 MM patients using an unbiased, high-throughput pipeline for therapeutic target discovery via single-cell transcriptomic profiling, yielding 38 MM marker genes encoding cell-surface proteins and 15 encoding intracellular proteins. Of these, 20 candidate genes were highlighted that are not yet under clinical study, 11 of which were previously uncharacterized as therapeutic targets. The findings were cross-validated using bulk RNA sequencing, flow cytometry, and proteomic mass spectrometry of MM cell lines and patient BM, demonstrating high overall concordance across data types. Independent discovery using bulk RNA sequencing reiterated top candidates, further affirming the ability of single-cell transcriptomics to accurately capture marker expression despite limitations in sample size or sequencing depth. Target dynamics and heterogeneity were further examined using both transcriptomic and immuno-imaging methods. In summary, this study presents a robust and broadly applicable strategy for identifying tumor markers to better inform the development of targeted cancer therapy. Significance: Single-cell transcriptomic profiling and multiomic cross-validation to uncover therapeutic targets identifies 38 myeloma marker genes, including 11 transcribing surface proteins with previously uncharacterized potential for targeted antitumor therapy.